Backs FY24 adjusted EBITDA view $18M-$22M. “We continued our strong financial performance during the first quarter with outstanding topline growth led by a 53% increase in telehealth revenue and over $5 million of cash flow from operations. For the fourth consecutive quarter we achieved positive cash flow from operations and generated positive net cash flow. Adjusting for the large increase in deferred revenue related to the continued over-performance in our GLP-1 weight management program, we generated strong cash-adjusted EBITDA and cash flow continued to outperform expectations. Given the strength of our combined telehealth businesses, we are raising our full-year 2024 revenue guidance to at least $205 million, up from prior guidance of at least $200 million,” added Marc Benathen, Chief Financial Officer of LifeMD.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFMD:
- LifeMD Welcomes Cardiology Expert Calum MacRae to Board
- LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition
- LifeMD enters strategic partnership with Withings Heath Solutions
- LifeMD management to meet with BTIG
- LifeMD appoints MacRae to board of directors